← Back to patent-cliff list
CAS 1227056-86-1
tert-butyl 4-(2-((2,4,6-trifluorophenoxy)methyl)phenyl)piperidine-1-carboxylate
Codes: TD-9855-005
Application context (from source-drug indications)
Multiple system atrophyAmpreloxetine直立性低血压Ampreloxetine单纯性自主神经衰竭AmpreloxetineParkinson's diseaseAmpreloxetineDrug-related adverse effects and reactionsAmpreloxetineAttention deficit hyperactivity disorderAmpreloxetine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ampreloxetine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(2-((2,4,6-trifluorophenoxy)methyl)phenyl)piperidine→tert-butyl 4-(2-formylphenyl)piperidine-1-carboxylate→tert-butyl 4-(2-(hydroxymethyl)phenyl)piperidine-1-carboxylate→tert-butyl 4-(2-((tosyloxy)methyl)phenyl)piperidine-1-carboxylate→2,4,6-trifluorophenol→tert-butyl 4-(2-((2,4,6-trifluorophenoxy)methyl)phenyl)piperidine-1-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.